Total Payments
$4,232
2024 Payments
$332.31
Companies
17
Transactions
165
Medicare Patients
336
Medicare Billing
$101,810
Payment Breakdown by Category
Food & Beverage$4,225 (99.8%)
Education$7.12 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,225 | 164 | 99.8% |
| Education | $7.12 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $963.81 | 12 | $0 (2024) |
| ABBVIE INC. | $538.43 | 32 | $0 (2024) |
| Axsome Therapeutics, Inc. | $462.93 | 7 | $0 (2024) |
| Shire North American Group Inc | $445.76 | 31 | $0 (2019) |
| Lundbeck LLC | $363.62 | 18 | $0 (2022) |
| Allergan, Inc. | $278.57 | 18 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $239.55 | 16 | $0 (2021) |
| Alkermes, Inc. | $207.46 | 7 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $124.99 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $115.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.31 | 6 | Teva Pharmaceuticals USA, Inc. ($124.99) |
| 2023 | $923.88 | 19 | Axsome Therapeutics, Inc. ($415.41) |
| 2022 | $307.34 | 19 | ABBVIE INC. ($218.67) |
| 2021 | $434.07 | 22 | AbbVie Inc. ($239.76) |
| 2020 | $246.86 | 13 | Lundbeck LLC ($111.79) |
| 2019 | $601.10 | 20 | Otsuka America Pharmaceutical, Inc. ($386.64) |
| 2018 | $455.72 | 29 | Shire North American Group Inc ($166.61) |
| 2017 | $930.75 | 37 | Otsuka America Pharmaceutical, Inc. ($318.69) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.03 | General |
| 09/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.12 | General |
| 09/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.08 | General |
| 08/12/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.93 | General |
| 07/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 04/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PSYCHIATRY | ||||||
| 04/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.49 | General |
| 02/28/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Neurology | ||||||
| 01/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 90 | 434 | $65,100 | $32,232 |
| 2022 | 2 | 92 | 318 | $47,700 | $24,672 |
| 2021 | 2 | 82 | 305 | $45,750 | $23,081 |
| 2020 | 2 | 72 | 296 | $44,400 | $21,825 |
Total Patients
336
Total Services
1,353
Medicare Billing
$101,810
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 217 | $32,550 | $21,040 | 64.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 45 | 217 | $32,550 | $11,192 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 159 | $23,850 | $15,971 | 67.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 46 | 159 | $23,850 | $8,701 | 36.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 153 | $22,950 | $14,853 | 64.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 41 | 152 | $22,800 | $8,228 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 148 | $22,200 | $13,175 | 59.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 36 | 148 | $22,200 | $8,649 | 39.0% |
About Dr. Marc Reiner, MD
Dr. Marc Reiner, MD is a Psychiatry healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003980772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Reiner, MD has received a total of $4,232 in payments from pharmaceutical and medical device companies, with $332.31 received in 2024. These payments were reported across 165 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,225).
As a Medicare-enrolled provider, Reiner has provided services to 336 Medicare beneficiaries, totaling 1,353 services with total Medicare billing of $101,810. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Atascadero, CA
- Active Since 11/17/2006
- Last Updated 03/23/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003980772
Products in Payments
- VRAYLAR (Drug) $697.87
- REXULTI (Drug) $689.85
- Auvelity (Drug) $443.76
- VYVANSE (Drug) $351.31
- ABILIFY MAINTENA (Drug) $332.03
- BRINTELLIX (Drug) $211.85
- Trintellix (Drug) $209.09
- ARISTADA (Drug) $207.46
- TRINTELLIX (Drug) $173.67
- MYDAYIS (Drug) $133.03
- UZEDY (Drug) $124.99
- APTIOM (Drug) $115.66
- INVEGA SUSTENNA (Drug) $99.09
- Evekeo (Drug) $98.30
- Dayvigo (Drug) $78.30
- QUVIVIQ (Drug) $64.59
- CAPLYTA (Drug) $44.05
- VIBERZI (Drug) $19.48
- Sunosi (Drug) $19.17
- BELSOMRA (Drug) $18.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Atascadero
Elouisa Dizon, Md, MD
Psychiatry — Payments: $6,979
Psychiatry $6,979
David Osuna, Md, MD
Psychiatry — Payments: $3,310
Psychiatry $3,310
Dawnmarie Risley-Childs, D.o, D.O
Psychiatry — Payments: $1,524
Psychiatry $1,524
Dr. Robin Johnson, M.d, M.D
Psychiatry — Payments: $995.83
Psychiatry $995.83
Dr. Haizhu Liu, M.d, M.D
Psychiatry — Payments: $941.56
Psychiatry $941.56
Dr. Valerie Verde, Md, MD
Psychiatry — Payments: $827.75
Psychiatry $827.75